The roles of IGF2 and DNMT methylation and elongase6 related fatty acids in metabolic syndrome
- 27 August 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 12 (20) , 10253-10262
Abstract
Methylation levels in IGF2 and DNMT3a genes may affect the risk of metabolic syndrome (MetS) in an ELOVL6 activity dependent way.Keywords
Funding Information
- Chinese Academy of Sciences (XDA26040304)
- Science and Technology Commission of Shanghai Municipality (STCSM-20ZR1466400)
- National Key Research and Development Program of China (2016YFD0400200)
This publication has 43 references indexed in Scilit:
- Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older ChineseThe American Journal of Clinical Nutrition, 2012
- Metabolic Syndrome and Risk of CancerDiabetes Care, 2012
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Epigenetics: Connecting Environment and Genotype to Phenotype and DiseaseJournal of Dental Research, 2009
- The Relationship between Dietary Fat and Fatty Acid Intake and Body Weight, Diabetes, and the Metabolic SyndromeAnnals of Nutrition and Metabolism, 2009
- Persistent epigenetic differences associated with prenatal exposure to famine in humansProceedings of the National Academy of Sciences, 2008
- Metabolic Syndrome and Incident DiabetesDiabetes Care, 2008
- Mouse Elovl-6 promoter is an SREBP targetBiochemical and Biophysical Research Communications, 2008
- Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)Drug Discovery Today, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005